Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 VaxartGenetic TechnologiesCytRxTrovaGeneEnzon Pharmaceuticals
SymbolNASDAQ:VXRTNASDAQ:GENEOTCMKTS:CYTRNASDAQ:TROVOTCMKTS:ENZN
Price Information
Current Price$0.37$2.29$0.29$1.05$0.23
52 Week RangeBuyN/ABuyBuyN/A
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyN/A
Consensus Price Target$4.00N/A$5.00$14.50N/A
% Upside from Price Target968.09% upsideN/A1,624.14% upside1,280.95% upsideN/A
Trade Information
Market Cap$5.94 million$10.10 million$9.76 million$6.68 million$10.28 million
Beta0.573.661.920.240.06
Average Volume1,599,34841,07223,146551,449102,059
Sales & Book Value
Annual Revenue$4.16 million$20,000.00$250,000.00$380,000.00$6.92 million
Price / Sales1.42504.9539.0217.081.49
CashflowN/AN/AN/AN/A$0.13 per share
Price / CashN/AN/AN/AN/A1.74
Book Value$1.57 per share$0.29 per share$0.61 per share$2.63 per share$0.34 per share
Price / Book0.247.900.480.400.68
Profitability
Net Income$-18,000,000.00$-4,600,000.00$-12,710,000.00$-16,460,000.00$5.85 million
EPS($2.65)N/A($0.29)($8.26)N/A
Trailing P/E RatioN/A0.00N/AN/A1.77
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-244.38%N/AN/A-3,424.46%N/A
Return on Equity (ROE)-131.05%N/A-33.74%-149.88%50.79%
Return on Assets (ROA)-48.79%N/A-27.77%-105.52%48.54%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.09%N/AN/A0.15%N/A
Current Ratio2.29%2.14%10.73%3.20%25.13%
Quick Ratio2.29%2.14%10.73%3.20%25.13%
Ownership Information
Institutional Ownership Percentage12.51%13.51%3.26%10.85%0.11%
Insider Ownership Percentage7.30%N/A6.90%2.00%0.06%
Miscellaneous
Employees34N/A6N/AN/A
Shares Outstanding15.78 million4.41 million33.64 million6.18 million44.22 million
Next Earnings DateN/AN/A11/1/2019 (Estimated)11/6/2019 (Estimated)11/6/2019 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableNot Optionable
 VaxartGenetic TechnologiesCytRxTrovaGeneEnzon Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel